Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
---|---|---|---|---|
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
US11179402 | CLARUS | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
Apr, 2026
(2 years from now) | |
US10617696 | CLARUS | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
Apr, 2030
(6 years from now) | |
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
US11331325 | CLARUS | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
Jan, 2027
(3 years from now) | |
US8241664 | CLARUS | Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same |
Mar, 2029
(5 years from now) | |
US8778916 | CLARUS | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
Apr, 2030
(6 years from now) | |
US11426416 | CLARUS | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
Apr, 2030
(6 years from now) | |
US10543219 | CLARUS | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
Apr, 2030
(6 years from now) | |
US11179403 | CLARUS | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
Apr, 2030
(6 years from now) | |
US8492369 | CLARUS | Oral testosterone ester formulations and methods of treating testosterone deficiency comprising same |
Dec, 2030
(7 years from now) |
Drug Exclusivity | Drug Exclusivity Expiration |
---|---|
New Product (NP) | Mar 27, 2022 |
Drugs and Companies using TESTOSTERONE UNDECANOATE ingredient
Market Authorisation Date: 27 March, 2019
Treatment: Method of treating testosterone deficiency; A method of treating testosterone deficiency in men
Dosage: CAPSULE;ORAL
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic